Mucosal immunization against hepatitis A: Antibody responses are enhanced by co-administration of synthetic oligodeoxynucleotides and a novel cationic lipid

  • Mitchell L
  • Joseph A
  • Kedar E
 et al. 
  • 15


    Mendeley users who have this article in their library.
  • 17


    Citations of this article.


Hepatitis A caused by hepatitis A virus (HAV) transmitted by the fecal-oral route, results in considerable morbidity and economic loss. Mucosal immunization can be more effective than conventional injection at inducing both local and systemic immunity to HAV. Here we show that co-administration of killed HAV with synthetic oligodeoxynucleotides (ODNs) containing CpG sequences, and a novel polycationic sphingolipid (CCS)/cholesterol liposomal delivery system, markedly enhances the HAV-specific antibody response at the intestinal interface, particularly when delivered intrarectally or intranasally, to Balb/c mice at low HAV doses. A mucosally delivered, antigen-sparing HAV vaccine that is easily administered without specialized equipment or personnel, is an attractive alternative for facilitating mass immunization in hepatitis A outbreaks. © 2006 Elsevier Ltd. All rights reserved.

Author-supplied keywords

  • Cationic lipid delivery system
  • CpG motifs
  • Hepatitis A
  • Synthetic ODN adjuvants

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Leslie Ann Mitchell

  • Aviva Joseph

  • Eli Kedar

  • Yechezkel Barenholz

  • Eitan Galun

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free